Abacavir And Lamivudine Tablet, Film Coated
Product Images NDC 42385-962

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abacavir And Lamivudine (NDC 42385-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Container Label (30's count))

Label for Abacavir and Lamivudine Tablets, USP, 600 mg/300 mg film-coated tablets for oral use. The label shows that each tablet contains 600 mg of abacavir and 300 mg of lamivudine. The package contains 30 tablets and is Rx only. Manufactured by Laurus Labs Limited and labeled for Laurus Generics Inc. Storage instructions and a barcode are also visible.*

FDA Label Image

Abacavir Structure (Al Structure 1)

Chemical structure diagram showing the active ingredient Abacavir in its sulfate form, indicated by H2SO4, as part of the Abacavir and Lamivudine medication composition.*

FDA Label Image

Lamivudine Structure (Al Structure 2)

Chemical structure diagram of Abacavir, showing its molecular arrangement with labeled atoms and bonds. This image depicts the active ingredient Abacavir, part of the combination drug Abacavir and Lamivudine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.